Diagnosis of amyotrophic lateral sclerosis in a patient treated with TNFα blockers for ankylosing spondylitis: Fortuitus association or new side effect of TNFα blockers?

Joint Bone Spine

Volumn 76, Issue 2, 2009, Pages 213-214

  Loustau, Valentine ^a   Foltz, Violaine ^a   Poulain, Cécile ^a   Rozenberg, Sylvie ^a   Bruneteau, Gaëlle ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Amyotrophic lateral sclerosis; Infliximab; Motor neuron disease; TNFa blockers

Indexed keywords

ALPHA TOCOPHEROL; INFLIXIMAB; RILUZOLE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANKYLOSING SPONDYLITIS; CASE REPORT; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; ELECTROPHYSIOLOGY; HUMAN; LETTER; RESPIRATORY FAILURE;

AMYOTROPHIC LATERAL SCLEROSIS; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DEMYELINATING DISEASES; FATAL OUTCOME; HUMANS; MIDDLE AGED; SPONDYLITIS, ANKYLOSING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 61449263593     PISSN: 1297319X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2008.07.004     Document Type: Letter

References (10)

1. Hamon M.A., Nicolas G., Deviere F., et al. Demyelinating neuropathy during anti-TNF alpha treatment with a review of the literature. Rev Neurol 163 (2007) 1232-1235
2. Scheinfeld N. Adalimumab: a review of side effects. Expert Opin Drug Saf 4 (2005) 637-641
3. Richez C., Blanco P., Lagueny A., et al. Neuropathy resembling CIDP in patients receiving tumor necrosis factor alpha blockers. Neurology 64 (2005) 1468-1470
4. Ghezzi P., and Mennini T. Tumor necrosis factor and motoneuronal degeneration: an open problem. Neuroimmunomodulation 9 (2001) 178-182
5. Poloni M., Faccheti D., Mai R., et al. Circulating levels of tumor necrosis factor-alpha and its soluble receptors are increased in the blood of patients with amyotrophic lateral sclerosis. Neurosci Lett 287 (2000) 211-214
6. Sathasivam S., and Shaw P.J. Apoptosis in amyotrophic lateral sclerosis: what is the evidence?. Lancet Neurol 4 (2005) 500-509
7. Puttaparthi K., and Elliott J.L. Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol 196 (2005) 441-451
8. West M., Mhatre M., Ceballos A., et al. The arachidonic acid 5-lipoxygenase inhibitor nordihydroguaiaretic acid inhibits tumor necrosis factor alpha activation of microglia and extends survival of G93A-SOD1 transgenic mice. J Neurochem 91 (2004) 133-143
9. Moisse K., and Strong M.J. Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762 (2006) 1083-1093
10. Gowing G., Dequen F., Soucy G., et al. Absence of tumor necrosis factor-α does not affect motor neuron disease caused by superoxyde dismutase 1 mutations. J Neurosci 26 (2006) 11397-11402